Alliance Pharma (APH)

 

APH Share PerformanceMore

52 week high53.50 14/09/16
52 week low40.50 27/06/16
52 week change 2.25 (4.81%)
4 week volume39,161,200 28/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Notification of Major Interest in Shares

RNS Number: 6866B Alliance Pharma PLC 05 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Alliance Pharma plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisitio...

Application for admission

RNS Number: 2497B Alliance Pharma PLC 31 March 2017 For immediate release 31 March 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a...

Full Year Results

RNS Number: 8463A Alliance Pharma PLC 29 March 2017 29 March 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Group") Results for the year ended 31 December 2016 Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, is pleased to announce its results for the year ended 31 December 2016. Financial Highlights Revenue up 102% at 97.5m...

Alliance Pharma settlement agreement with Sinclair

Alliance Pharma has reached agreement with Sinclair Pharma for compensation in connection with the material reductio...

Settlement Agreement with Sinclair Pharma plc

RNS Number: 0143A Alliance Pharma PLC 21 March 2017 For immediate release 21 March 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Settlement Agreement with Sinclair Pharma plc Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces today it has reached agreement with Sinclair Pharma plc ("Sinclair", AIM: S...

Alliance Pharma schedules FY results

Alliance Pharma will announce its preliminary results for the year ended 31 December on 29 March. At 9:59am: (LON:APH...

Notification of Preliminary Results

RNS Number: 2761Y Alliance Pharma PLC 02 March 2017 For immediate release 2 March 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Notification of Preliminary Results Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, will announce its preliminary results for the year ended 31 December 2016 on Wednesday 29 March ...

Director Deals - Alliance Pharma PLC (APH)

Peter Butterfield, Executive Director, exercised 90,222 shares in the company on the 14th February 2017 at a price of 33.25p...

Fundamental DataMore

P/E ratio12.727
EPS3.85
Dividend yield2.469 %

Equity Research (APH)

Alliance Pharma plc
01/02/2017
Early Equity (EEQP.NEX) 1.1p £7m FY Aug 16 results from the UK investment Company that provides equity and debt capital, along with strategic and operational counsel, to businesses that have the...
hardman & co
Alliance Pharma plc
25/01/2017
Alliance Pharma’s buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from...
hardman & co
Alliance Pharma plc
07/06/2016
Alliance Pharma has adopted a buy-and-build strategy to evolve through a series of 28 acquisitions into a profitable, cash generative, specialty pharma business. The acquisition of part of the...

Latest discussion posts More

  • Re: Chase dumped at least 7m share

    Clearly someone else wanted the shares. Sound and safe stock to hold, IMO. ws
    6-Apr-2017
    winningstreak
  • Chase dumped at least 7m share

    But sp holding up surprisingly well. imho.
    6-Apr-2017
    Cantseethewoodsforthetrees
  • Results

    Results look fine to me. Healthy growth in underlying EPS, nicely upped Dividend. Good long term investment this one, I would say. Share price likely to move up steadily. WS
    29-Mar-2017
    winningstreak

Users' HoldingsMore

Users who hold Alliance Pharma also hold..
LLOYDS GRP.25%
BP18%
TESCO17%
NATIONAL GRID16%
GLAXOSMITHKLINE15%

Codes & Symbols

ISINGB0031030819
SymbolsAPH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH